| PERIOD ENDING | 31-Dec-07 | 31-Dec-05 | 31-Dec-04 | | Total Revenue | 112,425,000 | 56,324,000 | 37,452,000 | | Cost of Revenue | 51,212,000 | 30,837,000 | 20,916,000 | | | Gross Profit | 61,213,000 | 25,487,000 | 16,536,000 | | | Operating Expenses | | Research Development | 881,000 | 399,000 | 248,000 | | Selling General and Administrative | 8,386,000 | 5,056,000 | 3,810,000 | | Non Recurring | 271,000 | 156,000 | 65,000 | | Others | 30,234,000 | 2,926,000 | 2,481,000 | | | | Total Operating Expenses | 39,772,000 | 8,537,000 | 6,604,000 | | | | Operating Income or Loss | 21,441,000 | 16,950,000 | 9,932,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,377,000) | (1,974,000) | (1,169,000) | | Earnings Before Interest And Taxes | 19,299,000 | 15,115,000 | 8,935,000 | | Interest Expense |
-
| 523,000 |
-
| | Income Before Tax | 19,299,000 | 14,592,000 | 8,935,000 | | Income Tax Expense | 5,888,000 | 4,441,000 | 2,231,000 | | Minority Interest | (273,000) | 35,000 | (514,000) | | | | Net Income From Continuing Ops | 13,138,000 | 10,186,000 | 6,190,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
| 158,000 |
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 13,138,000 | 10,344,000 | 6,190,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,138,000 | $10,344,000 | $6,190,000 |
|
0.34% Nasdaq 
0.05 (0.10%) 
Income Statement
